2017 / 01

Next Paper
DOI: 10.24075/brsmu.2017-01-08

ORIGINAL RESEARCH

Detecting occult hepatitis B when testing donated blood

Eremeeva ZhG1, Fazylov VH2
About authors

1 Republic Clinical Dermatovenerologic Dispensary, Kazan, Russia

2 Department of Infectious Diseases, Medico-Prophylactic Faculty,
Kazan State Medical University, Kazan, Russia

Correspondence should be addressed: Zhanna Eremeeva
prospekt Pobedy, d. 39, kv. 91, Kazan, Russia, 420110; ur.relbmar@kinnahz5nif

About paper

Acknowledgements: authors thank Ramil Turaev from the Republican Blood Center (Kazan, Russia) for the opportunity to work with donor cards and Center's reports.

Contribution of the authors to this work: Eremeeva ZhG — analysis of literature, data collection and analysis, drafting a manuscript; Fazylov VH — idea, research planning, data analysis and interpretation, editing the manuscript.

Received: 2017-02-01 Accepted: 2017-02-18 Published online: 2017-03-14
|
  1. Enticott JC, Kandane-Rathnayake RK. Prevalence versus incidence. Transfusion. 2012 Sep; 52 (9): 1868–70. DOI: 10.1111/j.1537-2995.2012.03687.x.
  2. Saraswat S, Banerjee K, Chaudhury N, Mahant T, Khandekar P, Gupta RK, et al. Post-transfusion hepatitis type B following multiple transfusions of HBsAg-negative blood. J Hepatol. 1996 Nov; 25 (5): 639–43.
  3. Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, et al. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion. 2007 Jul; 47 (7): 1197–205.
  4. Ivashkin VT, Morozova MA, Maevskaya MV, Sokolina IA, German YeN, Bundina MV. [Risk factors of development of hepatocellular carcinoma]. The Russian Journal of Gastroenterology, Hepatology and Coloproctology. 2009; (1): 4–15. Russian.
  5. Aleshkin VA, Zubkin ML, Selkova EP, Chervinko VI, Suslov AP, Ovchinnikov YuV, et al. [Epidemiological and clinical significance of "occult" HBV-infection]. Epidemiology and Infectious Diseases. Topical issues. 2015; (4): 55–64. Russian.
  6. Fazylov VH. [Etiological and pathogenetic aspects of diagnosis and treatment, of viral hepatitis]. Kazan Medical Journal. 2013; (6): 785–92.
  7. Hollinger FB. Hepatitis B virus infection and transfusion medicine: science and the occult. Transfusion. 2008 May; 48 (5): 1001–26. DOI: 10.1111/j.1537-2995.2008.01701.x.
  8. Zerbini A, Pilli M, Boni C, Fisicaro P, Penna A, Di Vincenzo P, et al. The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. Gastroenterology. 2008 May;134 (5): 1470–81.
  9. World Gastroenterology Organisation. WGO Global Guideline — Hepatitis B. Version 2.0. 2015 Feb. Available from: http://www.worldgastroenterology.org/UserFiles/file/guidelines/hepatitis-b- english-2015.pdf.
  10. Nechaev VV, Mukomolov SL, Nazarov VYu, Pozhidaeva LN, Chakhar`yan VV. [Chronic viral hepatitis: past, present and future]. Epidemiology and Infectious Diseases. 2013; (3): 4–10. Russian.
  11. Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008 Oct; 49 (4): 652–7. DOI: 10.1016/j.jhep.2008.07.014.
  12. Enaleeva DSh. [Modern aspects of the natural history of chronic hepatitis B-virus wi-B]. Kazan Medical Journal. 2012; 93 (2): 161– 6. Russian.
  13. Enaleeva DSh, Fazylov VH, Sozinov AS. Khronicheskie virusnye gepatity B, C i D. Moscow: MED-press-infrom; 2011. 464 p. Russian.
  14. Morozov IA, Ilchenko LYu, Fedorov IG, Gordeychuk IV, Gordeychuk IN, Knyazhentseva AK, et al [Hidden Hepatitis B: Clinical significance and problems of diagnostics]. Archive of Internal Medicine. 2012; (4): 39–45. Russian.
  15. Gordeychuk IV, Malinnikova EYu, Popova OE. [The latent hepatitis B in patients with HIV infection]. World of Viral Hepatitis. 2008; (6): 3–7. Russian.